# A Phase Ia Safety and Tolerability Study of BL-001

> **NCT05818306** · PHASE1 · COMPLETED · sponsor: **Bloom Science** · enrollment: 32 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** BL-001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05818306
- **Lead sponsor:** Bloom Science
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-20
- **Primary completion:** 2023-05-19
- **Final completion:** 2023-06-02
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2023-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05818306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05818306, "A Phase Ia Safety and Tolerability Study of BL-001". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05818306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*